UH Rainbow Babies & Children’s Hospital
Pediatrics, Division of Pediatric Gastroenterology, Hepatology & Nutrition
Dr. Ramy Sabe is a Pediatric Gastroenterologist who graduated from Ain Shams University in Cairo, Egypt in 2006. He completed his Pediatrics residency in 2013 at the Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center program in New York. He then moved to Ohio to complete his Pediatric Gastroenterology fellowship in 2016 at the UH Rainbow Babies & Children’s Hospital/Case Western Reserve University program. He is a faculty member at UH Rainbow Babies & Children’s Hospital and an Associate Professor of Pediatrics at the Case Western Reserve University. His areas of interest include pediatric endoscopy with specific interest in unsedated transnasal endoscopy (TNE), aerodigestive diseases, and eosinophilic gastrointestinal disorders, and is a member of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition endoscopy & procedures committee, TNE special interest group (SIG) and aerodigestive SIG. He was among the early endoscopists to start an unsedated transnasal endoscopy program in children and young adults in the United States. Dr. Sabe enjoys family time, watching and playing football (AKA soccer), meditation and Egyptian food!

Presenter of 2 Presentations

NASAL ENDOSCOPY (ID 1706)

Session Type
Endoscopy Learing Zone (ELZ)
Date
Sat, 20.05.2023
Session Time
11:00 - 12:30
Room
Hall N
Lecture Time
11:00 - 11:00

G-O019 - USE OF A NOVEL ULTRATHIN GASTROSCOPE FOR UNSEDATED TRANSNASAL ENDOSCOPY IN CHILDREN AND ADULTS FOR EVALUATION OF UPPER GASTROINTESTINAL TRACT DISORDERS (ID 1371)

Session Type
Gastroenterology
Date
Sat, 20.05.2023
Session Time
08:30 - 10:30
Room
Hall G
Lecture Time
09:49 - 10:01

Abstract

Objectives and Study

Transnasal endoscopy (TNE) allows for endoscopic evaluation of the upper gastrointestinal tract while avoiding general anesthesia risk. In the pediatric age group, often bronchoscopes are used for performing TNEs, which precludes the evaluation of the stomach and duodenum due to shorter length and overall suboptimal visualization. In this study, we evaluated a novel ultrathin gastroscope (EvoEndo®) in children and adults.

Methods

This is a multicenter retrospective study between May and November 2022. There were a total of 6 participating sites in USA. Data was collected from electronic medical record. Primary outcome was safety and efficacy of EvoEndo® single use transnasal gastroscope. Secondary outcomes included procedure and encounter duration, and biopsy adequacy.

Results

Thirty-six patients were recruited. Indications included dysphagia, eosinophilic esophagitis and esophageal varices surveillance. Mean age was 16.1 years ± 6.1 (6-37 years) with male predominance (86.1%). 35/36 subjects underwent TNE for varying clinical indications and targeted anatomy. One procedure was aborted prior to initiation. 3 subjects underwent transnasal esophagoscopy (TN-Eso), 26 transnasal gastroscopy (TN-EG), and 3 transnasal esophagogastroduodenoscopy (TN-EGD). The procedure was successful in 91.4%. 3 procedures were unable to be completed. 50% underwent TNE for the first time. Biopsies were performed in all completed procedures except the 2 patients undergoing esophageal varices surveillance, and were adequate for histopathological analysis. Median procedure duration was 11 minutes (IQR: 7-16 minutes) and median visit duration was 33.5 minutes (IQR: 30-39 minutes). No significant adverse events occurred.

Conclusions

Ultrathin TNE using the EvoEndo® single use gastroscope was well tolerated and safe in the pediatric and adult age groups with a success rate similar to previously reported studies. User feedback noted EvoEndo’s single use gastroscopes provided improved visualization, further reach into the upper gastrointestinal tract, and a larger working channel allowing for diagnostic EGD in an efficient ambulatory setting without the need for general anesthesia.

Hide